Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has earned an average recommendation of “Buy” from the seven research firms that are currently covering the firm, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have issued ratings on the stock in the last […]
Olema Pharmaceuticals (NASDAQ:OLMA) Now Covered by Citigroup themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) were down 4% on Friday . The stock traded as low as $11.03 and last traded at $11.03. Approximately 446,428 shares changed hands during mid-day trading, a decline of 29% from the average daily volume of 628,771 shares. The stock had previously closed at $11.49. […]
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) traded up 8.3% during mid-day trading on Wednesday . The company traded as high as $17.20 and last traded at $17.20. 34,407 shares were traded during trading, a decline of 88% from the average session volume of 288,567 shares. The stock had previously closed at $15.88. Wall […]
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) fell 4.9% during trading on Monday . The company traded as low as $15.01 and last traded at $15.06. 209,613 shares were traded during trading, a decline of 27% from the average session volume of 285,469 shares. The stock had previously closed at $15.83. Analyst Ratings Changes […]